Emmecell, a clinical-stage biotechnology company pioneering magnetic cell delivery technologies for ophthalmic disease, today ...

BoomRx, the fastest-growing national pharmaceutical technology platform that simplifies prescription sourcing and fulfillment ...

This agreement reinforces Credence’s role as a trusted partner to the pharmaceutical industry in advancing patient care. This ...

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO ...

The approved transition to PRF Technologies Ltd. is intended to reflect the Company’s strategy to build long-term value through diversification, platform scalability, and disciplined execution across ...

Sanofi may rebid for Ocular Therapeutix, Inc. to boost retinal therapeutics ahead of Dupixent patent expiry. Click for more ...

Technology spending is no longer judged solely by delivery or performance metrics, and CIOs and IT leaders are increasingly held accountable for how effectively IT investments translate into business ...

Analysis of 20 years of data highlights differences in reimbursement trends across ophthalmology subspecialties and practice ...

On the largest civilian hospital ship in the world, Australian volunteers provide life-changing healthcare that is ...

Building on previously disclosed progress toward an Investigational New Drug (IND) submission, PainReform and LayerBio are advancing IND-enabling activities, with preparation and development efforts ...

BOSTON, MA, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- EyeCool Therapeutics, a clinical-stage ophthalmic ...

DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) (“DiagnosTear” or the “Company”), a fast-growing innovator in point-of-care ...